Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study

and for the ERIVANCE BCC Investigators

Research output: Contribution to journalArticlepeer-review

118 Scopus citations

Fingerprint Dive into the research topics of 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study'. Together they form a unique fingerprint.

Medicine & Life Sciences